{"id":"effcamgcit","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug combines effervescent calcium citrate with magnesium and additional citrate to enhance absorption and utilization of these essential minerals. Citrate acts as a carrier to improve bioavailability of calcium and magnesium while also providing alkalinizing effects. This formulation is designed to support bone mineralization, muscle function, and metabolic health.","oneSentence":"EffCaMgCit is a combination supplement that provides bioavailable forms of calcium, magnesium, and citrate to support mineral homeostasis and bone health.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:10:30.843Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Calcium and magnesium supplementation for bone health and mineral deficiency prevention"}]},"trialDetails":[{"nctId":"NCT05998863","phase":"PHASE3","title":"EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-04-19","conditions":"Osteoporosis, Hypomagnesemia","enrollment":56},{"nctId":"NCT03565913","phase":"PHASE2, PHASE3","title":"Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-01-22","conditions":"CKD Stage 5","enrollment":269},{"nctId":"NCT03812380","phase":"PHASE3","title":"Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-01-01","conditions":"Osteoporosis, Hypomagnesemia","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Effervescent calcium magnesium citrate"],"phase":"phase_3","status":"active","brandName":"EffCaMgCit","genericName":"EffCaMgCit","companyName":"University of Texas Southwestern Medical Center","companyId":"university-of-texas-southwestern-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"EffCaMgCit is a combination supplement that provides bioavailable forms of calcium, magnesium, and citrate to support mineral homeostasis and bone health. Used for Calcium and magnesium supplementation for bone health and mineral deficiency prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}